Based on 1 analysts giving stock ratings to enVVeno Medical Corp in the past month.
In the current month, NVNO has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NVNO average Analyst price target in the last month is 30.000.
Based on analysts' estimates, NVNO EPS is projected to reach -2.350 in FY2026Q4, following reported EPS of -6.293 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -6.29, while enVVeno Medical CorpNVNO's earnings per share (EPS) for the previous quarter was USD -5.37. EPS for the next quarter is expected at USD -2.35.